Clinical Trials
13 trialsNCT07606612 2026-05-26
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT05522491 2025-12-11
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting
NCT07245901 2025-11-24
Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2 Not yet recruiting
NCT07140393 2025-08-24
A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06949761 2025-04-29
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06524024 2025-02-10
DC-CTL
Zhengzhou Revo-Gene Technology Co., LTD
Phase NA Not yet recruiting
NCT05954091 2024-12-27
OH2 Administered by Intratumoral Injection
Binhui Biopharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT06541301 2024-11-19
PICCHEST
European Institute of Oncology
Phase NA Not yet recruiting
NCT06613152 2024-09-25
HS-IT201 Injection in the Treatment of Advanced Solid Tumors
Qingdao Sino-Cell Biomedicine Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT06537505 2024-08-05
A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors
Beidahuang Industry Group General Hospital
Phase 2 Not yet recruiting
NCT06245018 2024-02-07
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
Nuwacell Biotechnologies Co., Ltd.
Phase NA Not yet recruiting
NCT05971576 2023-08-02
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT05971589 2023-08-02
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting